Radiation Therapy: What It Is, How It Helps
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Comprehensive Qa for Radiation Oncology
AAPM REPORT NO. 46 COMPREHENSIVE QA FOR RADIATION ONCOLOGY Published for the American Association of Physicists in Medicine by the American Institute of Physics AAPM REPORT NO. 46 COMPREHENSIVE QA FOR RADIATION ONCOLOGY REPORT OF TASKGROUP NO.40 RADIATION THERAPY COMMITTEE AAPM Members Gerald J. Kutcher, TG Chair Lawrence Coia Michael Gillin William F. Hanson Steven Leibel Robert J. Morton Jatinder R. Palta James A. Purdy Lawrence E. Reinstein Goran K. Svensson Mona Weller Linda Wingfield Reprinted from MEDICAL PHYSICS, Volume 21, Issue 4, 1994 April 1994 Published by the American Association of Physicists in Medicine DISCLAIMER: This publication is based on sources and information believed to be reliable, but the AAPM and the editors disclaim any warranty or liability based on or relating to the contents of this publication. The AAPM does not endorse any products, manufacturers, or suppliers. Nothing in this publication should be interpreted as implying such endorsement. Further copies of this report may be obtained from: AAPM One Physics Ellipse College Park, MD 20740-3846 301/209-3350 International Standard Book Number: l-56396-401 -5 Copyright © 1994 by the American Association of Physicists in Medicine All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means (electronic, mechanical, photocopying, recording, or otherwise) without the prior written permission of the publisher. Printed in the United States of America Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40 Gerald J. Kutcher Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 Lawrence Coia Department of Radiation Oncology, Fox Chase Cancer Center/University of Pennsylvania, Philadelphia, Pennsylvania 19111 Michael Gillin Radiation Therapy Department, Medical College of Wisconsin, Milwaukee, Wisconsin 53226 William F. -
Practice Standards for Medical Imaging and Radiation Therapy
The ASRT Practice Standards for Medical Imaging and Radiation Therapy Radiation Therapy ©2019 American Society of Radiologic Technologists. All rights reserved. Reprinting all or part of this document is prohibited without advance written permission of the ASRT. Send reprint requests to the ASRT Publications Department, 15000 Central Ave. SE, Albuquerque, NM 87123-3909. Effective June 23, 2019 Table of Contents Preface .......................................................................................................................................................... 1 Format ....................................................................................................................................................... 1 Introduction .................................................................................................................................................. 3 Definition .................................................................................................................................................. 3 Education and Certification ...................................................................................................................... 5 Medical Imaging and Radiation Therapy Scope of Practice .......................................................................... 6 Standards ...................................................................................................................................................... 8 Standard One – Assessment .................................................................................................................... -
Intensity-Modulated Radiation Therapy (Imrt) Hs-094
INTENSITY-MODULATED RADIATION THERAPY (IMRT) HS-094 Easy Choice Health Plan, Inc. Exactus Pharmacy Solutions, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Incorporated WellCare Health Insurance of Arizona, Inc., operating in Hawai‘i as ‘Ohana Health Plan, Inc. WellCare of Kentucky, Inc. WellCare Health Plans of Kentucky, Inc. WellCare Health Plans of New Jersey, Inc. WellCare of Connecticut, Inc. WellCare of Florida, Inc., operating in Florida as Staywell Intensity-Modulated WellCare of Georgia, Inc. Radiation Therapy WellCare of Louisiana, Inc. Policy Number: HS-094 WellCare of New York, Inc. WellCare of South Carolina, Inc. Original Effective Date: 4/2/2009 WellCare of Texas, Inc. Revised Date(s): 4/30/2010; 4/30/2011; WellCare Prescription Insurance, Inc. 4/5/2012; 4/11/2013; 3/6/2014; 3/5/2015; Windsor Health Plan, Inc. 3/3/2016 APPLICATION STATEMENT The application of the Clinical Coverage Guideline is subject to the benefit determinations set forth by the Centers for Medicare and Medicaid Services (CMS) National and Local Coverage Determinations and state-specific Medicaid mandates, if any. Clinical Coverage Guideline page 1 Original Effective Date: 4/2/2009 - Revised: 4/30/2010, 4/30/2011, 4/5/2012, 4/11/2013, 3/6/2014, 3/5/2015, 3/3/2016 INTENSITY-MODULATED RADIATION THERAPY (IMRT) HS-094 DISCLAIMER The Clinical Coverage Guideline is intended to supplement certain standard WellCare benefit plans. The terms of a member’s particular Benefit Plan, Evidence of Coverage, Certificate of Coverage, etc., may differ significantly from this Coverage Position. For example, a member’s benefit plan may contain specific exclusions related to the topic addressed in this Clinical Coverage Guideline. -
1 Work-Related Musculoskeletal Disorders in Radiation Therapists
Work-related Musculoskeletal Disorders in Radiation Therapists: An Exploration of Self-Reported Symptoms Thesis Presented in Partial Fulfillment of the Requirements for the Degree Master of Science in the Graduate School of The Ohio State University By Haley Griffin, B.S. Graduate Program in Allied Medicine The Ohio State University 2018 Thesis Committee Kevin D. Evans, PhD, Advisor Carolyn M. Sommerich, PhD, CPE Maryanna Klatt, PhD 1 Copyrighted by Haley Griffin 2018 2 Abstract This study explores the self-reported symptoms of musculoskeletal disorders in Radiation Therapists (RTT) registered by the American Registry of Radiologic Technologists (ARRT), in the United States. There was a gap in the literature focusing on RTTs unique set of workplace injuries. Utilizing a nationwide survey the anatomical areas where the most RTTs experienced pain were discovered along with other demographic factors in order to seek relationships between this demographic data with the occurrence of musculoskeletal symptoms. Different aspects of perceived physical and mental demand will also be discussed. Suggestions for possible future directions to ameliorate this problem will also be discussed, such as ergonomic training. The multivariate interaction theory describes how injury causation is due to biomechanical hazards in the workplace. This explains how movements while transferring or positioning patients for treatment has the potential for RTTs to incur musculoskeletal injuries. Data was collected by administering a nationwide online survey to a large convenient sample of RTTs. The instrument contained questions about what common work related symptoms are encountered in the profession. Data analysis allowed for exploring some relationships between different variables, their occurrence, and the anatomical site of musculoskeletal symptoms. -
Manual for ACRO Accreditation March 2016
American College of Radiation Oncology Manual for ACRO Accreditation March 2016 Powered by Patients First Our Focus is Radiation Oncology Safety! ACKNOWLEDGMENTS ACRO expresses its appreciation for the significant contribution and leadership of Jaroslaw Hepel, MD, FACRO, Chair of the ACRO Standards Committee, and ACRO Accreditation Medical Director, for his un- tiring efforts to bring this version of the Manual for ACRO Accreditation to publication. Thanks also go to Arve Gillette, MD, FACRO, ACRO Chancellor and a former President, and ACRO Ac- creditation Medical Director during 2011, who initiated most of the new procedures incorporated in the accreditation program when it was reintroduced after a board imposed administrative review for most of 2010. Appreciation also is expressed to Ralph Dobelbower, MD, FACRO, the founding medical director of ACRO Accreditation; Gregg Cotter, MD, FACRO, medical director after Dr. Dobelbower; and Ishmael Parsai, PhD, FACRO, physics chairman for many years; for their collective leadership in building the accreditation program from its inception in 1995. In addition, appreciation is expressed for ongoing support and commitment to the accreditation process to all the following ACRO members who have contributed, and continue to contribute, to the success of ACRO Accreditation: ACRO Executive Committee | Drs. James Welsh (President), Eduardo Fernandez (Vice President), William Rate (Secretary-Treasurer), and Arno Mundt (Chairman) ACRO Chancellors | Drs. Joanne Dragun, Gregg Franklin, Shane Hopkins, Sheila Rege, Charles Thomas, II, Harvey Wolkov, Catheryn Yashar, and Luther Brady (ex officio) ACRO Accreditation Disease Site Team Leaders | Dr. Jaroslaw Hepel (Breast Cancer); Drs. William Regine & Navesh Sharma (Gastrointestinal Cancer); Dr. Peter Orio III (Genitourinary Cancer); Dr. -
How Do Radioactive Materials Move Through the Environment to People?
5. How Do Radioactive Materials Move Through the Environment to People? aturally occurring radioactive materials Radionuclides can be removed from the air in Nare present in our environment and in several ways. Particles settle out of the our bodies. We are, therefore, continuously atmosphere if air currents cannot keep them exposed to radiation from radioactive atoms suspended. Rain or snow can also remove (radionuclides). Radionuclides released to them. the environment as a result of human When these particles are removed from the activities add to that exposure. atmosphere, they may land in water, on soil, or Radiation is energy emitted when a on the surfaces of living and non-living things. radionuclide decays. It can affect living tissue The particles may return to the atmosphere by only when the energy is absorbed in that resuspension, which occurs when wind or tissue. Radionuclides can be hazardous to some other natural or human activity living tissue when they are inside an organism generates clouds of dust containing radionu- where radiation released can be immediately clides. absorbed. They may also be hazardous when they are outside of the organism but close ➤ Water enough for some radiation to be absorbed by Radionuclides can come into contact with the tissue. water in several ways. They may be deposited Radionuclides move through the environ- from the air (as described above). They may ment and into the body through many also be released to the water from the ground different pathways. Understanding these through erosion, seepage, or human activities pathways makes it possible to take actions to such as mining or release of radioactive block or avoid exposure to radiation. -
Chapter 12: Quality Assurance of External Beam Radiotherapy
Chapter 12: Quality Assurance of External Beam Radiotherapy Set of 146 slides based on the chapter authored by D. I. Thwaites, B. J. Mijnheer, J. A. Mills of the IAEA publication (ISBN 92-0-107304-6): Review of Radiation Oncology Physics: A Handbook for Teachers and Students Objective: To familiarize the student with the need and the concept of a quality system in radiotherapy as well as with recommended quality procedures and tests. Slide set prepared in 2006 by G.H. Hartmann (Heidelberg, DKFZ) Comments to S. Vatnitsky: [email protected] Version 2012 IAEA International Atomic Energy Agency CHAPTER 12. TABLE OF CONTENTS 12.1 Introduction 12.2 Managing a Quality Assurance Program 12.3 Quality Assurance Program for Equipment 12.4 Treatment Delivery 12.5 Quality Audit IAEA Review of Radiation Oncology Physics: A Handbook for Teachers and Students - 12.Slide 1 12.1 INTRODUCTION 12.1.1 Definitions Commitment to Quality Assurance (QA) needs a sound familiarity with some main relevant terms such as: Quality Quality Assurance System QA in Quality Radiotherapy Control Quality Standards Definitions are given next. IAEA Review of Radiation Oncology Physics: A Handbook for Teachers and Students - 12.1.1. Slide 1 12.1 INTRODUCTION 12.1.1 Definitions Quality Assurance Quality Assurance is all those planned and systematic actions necessary to provide adequate confidence that a product or service will satisfy the given requirements for quality. As such QA is wide ranging, covering • Procedures; • Activities; • Actions; • Groups of staff. Management of a QA program is also called Quality System Management. IAEA Review of Radiation Oncology Physics: A Handbook for Teachers and Students - 12.1.1. -
Radionuclides (Including Radon, Radium and Uranium)
Radionuclides (including Radon, Radium and Uranium) Hazard Summary Uranium, radium, and radon are naturally occurring radionuclides found in the environment. No information is available on the acute (short-term) noncancer effects of the radionuclides in humans. Animal studies have reported inflammatory reactions in the nasal passages and kidney damage from acute inhalation exposure to uranium. Chronic (long-term) inhalation exposure to uranium and radon in humans has been linked to respiratory effects, such as chronic lung disease, while radium exposure has resulted in acute leukopenia, anemia, necrosis of the jaw, and other effects. Cancer is the major effect of concern from the radionuclides. Radium, via oral exposure, is known to cause bone, head, and nasal passage tumors in humans, and radon, via inhalation exposure, causes lung cancer in humans. Uranium may cause lung cancer and tumors of the lymphatic and hematopoietic tissues. EPA has not classified uranium, radon or radium for carcinogenicity. Please Note: The main sources of information for this fact sheet are EPA's Integrated Risk Information System (IRIS) (5), which contains information on oral chronic toxicity and the RfD for uranium, and the Agency for Toxic Substances and Disease Registry's (ATSDR's) Toxicological Profiles for Uranium, Radium, and Radon. (1) Uses Uranium is used in nuclear power plants and nuclear weapons. Very small amounts are used in photography for toning, in the leather and wood industries for stains and dyes, and in the silk and wood industries. (2) Radium is used as a radiation source for treating neoplastic diseases, as a radon source, in radiography of metals, and as a neutron source for research. -
6.2.43A Radiation-Dominated Model of the Universe
6 BIG BANG COSMOLOGY – THE EVOLVING UNIVERSE 6.2.43A radiation-dominated model of the Universe R We have just seen that in the early Universe, the dominant energy density is that due to the radiation within the Universe. The Friedmann equation that was described in Chapter 5 (Box 5.4) can be solved for such conditions and the way in which the scale factor varies with time for such a model is shown in Figure 6.7. One important feature of such a model is that the scale factor varies in the following way: R(t) ∝ t1/2 (6.17) 0 t −4 Because the energy density of radiation is dominant for times when R(t)/R(t0) < 10 , all cosmological models which start at t = 0 with R(0) = 0, will go through a phase Figure 6.73The evolution of the that is well described by this radiation-dominated model. Thus we are in the rather scale factor with time in a remarkable position that regardless of which type of cosmological model best cosmological model in which the dominant contribution to the describes the Universe at the present, we can be reasonably confident that we energy density arises from the know how the scale factor varied with time in the first few tens of thousands of radiation within the Universe years of the big bang. (i.e. during the radiation-dominated However, the temperature of the background radiation varies with scale factor era). according to T(t) ∝ 1/R(t) (Equation 6.6). It follows that during the radiation- dominated era the temperature of the background radiation varies with time according to T(t) ∝ t −1/2 (6.18) This describes how temperature changes with time in an expanding universe where the energy density of radiation is the dominant component. -
PE1128 Radiation Exposure in Medical Imaging
Radiation Exposure in Medical Imaging This handout answers questions about radiation exposure and what Seattle Children’s Hospital is doing to keep your child safe. Medical imaging uses machines and techniques to provide valuable information about your child’s health. It plays an important role in helping your doctor make the correct diagnosis. Some of these machines use radiation to get these images. We are all exposed to small amounts of radiation in normal daily life from soil, rocks, air, water and even some of the foods we eat. This is called background radiation. The amount of background radiation that you are exposed to depends on where you live and varies throughout the country. The average person in the United States receives about 3 milli-Sieverts (mSv) per year from background radiation. A mSv is a unit of measurement for radiation, like an inch is a unit of length. Which medical MRI and ultrasound do not use ionizing (high-energy) radiation to make imaging exams images. MRI uses magnets and radio waves, and ultrasound uses sound waves. use radiation? Diagnostic An X-ray is a form of energy that can pass through your child’s bones and Radiography tissues to create an image. The image created is called a radiograph, sometimes referred to as an “X-ray.” X-rays are used to detect and diagnose conditions in the body. CT scan A CT (computed tomography) scan, sometimes called a “CAT scan,” uses X-rays, special equipment, and computers to make pictures that provide a multidimensional view of a body part. -
Job Description for Job Title
UW HEALTH JOB DESCRIPTION RADIATION THERAPIST LEAD Job Code: 500031 FLSA Status: Non Exempt Mgt. Approval: T Yambor Date: 7-17 Department : Radiation Oncology HR Approval: CMW Date: 7-17 JOB SUMMARY The Radiation Therapist Lead provides leadership, training and guidance to lower level staff, supports the Supervisor and performs complex and specialized radiation oncology work. Under the direction of the Supervisor, the Radiation Therapist Lead may develop training and provide orientation for new therapists and/or students, review and propose updates to procedure manuals and protocols, integrate new technical procedures and coordinate group projects. The incumbent also assists the Supervisor in identifying problems, recommending solutions and assisting in the improvement of technical and patient service programs. Therapists at this level are expected to have a thorough understanding and proficiency in the procedures performed in the Radiation Oncology Department. The Radiation Therapist Lead will perform and train lower level staff on the performance of routine, complex and specialized work as well as assist in the implementation of new technology. Complex patient procedures include: stereotactic radiosurgery (SRS); fractionated stereotactic radiotherapy (FSRT); pulsed reduced dose rate treatments (PRDR); advanced use of the ARIA Radiation Oncology software, OSMS, SBRT, Respiratory Management, View Ray treatments, and complex tumor localization and tracking procedures. The incumbent provides patient care within a broad range of health care needs and is responsible for patient scheduling, simulations, anticipating changes in field boosts, and recognizing dose limitations. The Radiation Therapist Lead has significant responsibility for the efficient operation of the treatment delivery work area, communicating and coordinating daily operations with medical staff and residents, nurses, physics and dosimetry, front desk and ancillary services such as social work and dietary. -
General Terms for Radiation Studies: Dose Reconstruction Epidemiology Risk Assessment 1999
General Terms for Radiation Studies: Dose Reconstruction Epidemiology Risk Assessment 1999 Absorbed dose (A measure of potential damage to tissue): The Bias In epidemiology, this term does not refer to an opinion or amount of energy deposited by ionizing radiation in a unit mass point of view. Bias is the result of some systematic flaw in the of tissue. Expressed in units of joule per kilogram (J/kg), which design of a study, the collection of data, or in the analysis of is given the special name Agray@ (Gy). The traditional unit of data. Bias is not a chance occurrence. absorbed dose is the rad (100 rad equal 1 Gy). Biological plausibility When study results are credible and Alpha particle (ionizing radiation): A particle emitted from the believable in terms of current scientific biological knowledge. nucleus of some radioactive atoms when they decay. An alpha Birth defect An abnormality of structure, function or body particle is essentially a helium atom nucleus. It generally carries metabolism present at birth that may result in a physical and (or) more energy than gamma or beta radiation, and deposits that mental disability or is fatal. energy very quickly while passing through tissue. Alpha particles cannot penetrate the outer, dead layer of skin. Cancer A collective term for malignant tumors. (See “tumor,” Therefore, they do not cause damage to living tissue when and “malignant”). outside the body. When inhaled or ingested, however, alpha particles are especially damaging because they transfer relatively Carcinogen An agent or substance that can cause cancer. large amounts of ionizing energy to living cells.